TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $575,108 | +2.7% | 37,176 | +4.3% | 0.17% | +1.8% |
| Q2 2023 | $559,913 | -1.9% | 35,641 | +2.9% | 0.16% | -7.3% |
| Q1 2023 | $570,811 | +6.5% | 34,637 | +0.8% | 0.18% | -1.7% |
| Q4 2022 | $535,945 | +11.0% | 34,355 | -7.8% | 0.18% | +0.6% |
| Q3 2022 | $483,000 | -17.9% | 37,275 | -10.9% | 0.18% | -10.4% |
| Q2 2022 | $588,000 | +11.2% | 41,856 | +13.2% | 0.20% | +28.0% |
| Q1 2022 | $529,000 | +14.8% | 36,966 | +9.2% | 0.16% | +24.6% |
| Q4 2021 | $461,000 | -0.6% | 33,851 | +19.6% | 0.13% | +13.5% |
| Q3 2021 | $464,000 | – | 28,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |